Alcon Total Assets 2019-2023 | ALC
Alcon total assets from 2019 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Alcon total assets for the quarter ending December 31, 2023 were $29.614B, a 1.54% increase year-over-year.
- Alcon total assets for 2023 were $29.614B, a 1.54% increase from 2022.
- Alcon total assets for 2022 were $29.165B, a 4.16% increase from 2021.
- Alcon total assets for 2021 were $27.999B, a 1.45% increase from 2020.
| Alcon Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $29,614 |
| 2022 | $29,165 |
| 2021 | $27,999 |
| 2020 | $27,600 |
| 2019 | $27,655 |
| 2018 | $27,062 |
| Alcon Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $29,614 |
| 2023-09-30 | $29,369 |
| 2023-06-30 | $29,209 |
| 2023-03-31 | $29,291 |
| 2022-12-31 | $29,165 |
| 2022-09-30 | $27,796 |
| 2022-06-30 | $27,727 |
| 2022-03-31 | $27,790 |
| 2021-12-31 | $27,999 |
| 2021-09-30 | $27,802 |
| 2021-06-30 | $27,750 |
| 2021-03-31 | $27,368 |
| 2020-12-31 | $27,600 |
| 2020-09-30 | $27,414 |
| 2020-06-30 | $27,481 |
| 2020-03-31 | $27,199 |
| 2019-12-31 | $27,655 |
| 2019-09-30 | $27,633 |
| 2019-06-30 | $27,774 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $38.723B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.482B | 26.59 |
| Intuitive Surgical (ISRG) | United States | $131.844B | 79.42 |
| Edwards Lifesciences (EW) | United States | $50.799B | 33.06 |
| DexCom (DXCM) | United States | $50.060B | 75.83 |
| IQVIA Holdings (IQV) | United States | $42.279B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $38.873B | 45.31 |
| STERIS (STE) | Ireland | $20.261B | 23.98 |
| Waters (WAT) | United States | $18.737B | 26.89 |
| Hologic (HOLX) | United States | $17.905B | 19.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.708B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.452B | 15.38 |
| ShockWave Medical (SWAV) | United States | $12.372B | 85.23 |
| Sysmex ADR (SSMXY) | Japan | $10.492B | 32.90 |
| Teleflex (TFX) | United States | $9.964B | 15.65 |
| Penumbra (PEN) | United States | $7.957B | 98.22 |
| Masimo (MASI) | United States | $7.091B | 39.77 |
| Globus Medical (GMED) | United States | $6.827B | 21.64 |
| Glaukos (GKOS) | United States | $4.964B | 0.00 |
| TransMedics (TMDX) | United States | $3.847B | 367.50 |
| Integer Holdings (ITGR) | United States | $3.678B | 22.22 |
| LivaNova (LIVN) | United Kingdom | $3.391B | 20.14 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.700B | 18.52 |
| Nihon Kohden (NHNKY) | Japan | $2.423B | 20.49 |
| Inari Medical (NARI) | United States | $2.419B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.337B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.294B | 9.41 |
| RxSight (RXST) | United States | $2.108B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.813B | 0.00 |
| Veracyte (VCYT) | United States | $1.539B | 0.00 |
| OPKO Health (OPK) | United States | $0.885B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.868B | 16.06 |
| Artivion (AORT) | United States | $0.838B | 96.81 |
| Paragon 28 (FNA) | United States | $0.817B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.795B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.738B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.594B | 20.18 |
| IRadimed (IRMD) | United States | $0.532B | 30.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.460B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
| NeuroPace (NPCE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.382B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.341B | 11.47 |
| AxoGen (AXGN) | United States | $0.287B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| CVRx (CVRX) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.90 |
| Alpha Tau Medical (DRTS) | Israel | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.087B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.059B | 120.33 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.053B | 0.00 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |